Answer
Regadenoson is expected to have no or negligible influence on driving ability once treatment is complete and adverse reactions have resolved.
Sources for this answer
- Rapiscan 400 microgram solution for injectionGE Healthcare Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 3Document updated
Sources checked